Clinical Exome Solution (CES v3)

The NGS Clinical Exome Solution (CES v3) of SOPHiA GENETICS covers the coding regions (± 5 bp of intronic regions) of 4,728 genes, the entire mitochondrial genome and ~200 non-coding variants with known pathogenicity in deep introns/enhancer/promoter genes. This new and improved probe design of the v3 provides increased capacity for detection of rare and inherited disorders.

  • Accurate analysis of multiple type of variants (SNVs, Indels and CNVs).
  • High on-target reads percentage and coverage uniformity even in GC-rich regions.

With the clinical exome study for clinical diagnosis, mutations in genes not related to the clinical phenotype of the patient but with clinical relevance can be detected. Exome sequencing thus helps early detection and early treatment of this genetic diseases.

CES v3 offers a streamlined end-to-end workflow (from sample to variant report), making it faster and easier to assessment of challenging Mendelian disorders, freeing up time and resources.

flujo
Clinical Exome Solution (CES v3) 8

This NGS solution includes a capture-based target enrichment kit, as well as the functionality and analytical capabilities of the SOPHiA DDM™ platform for data interpretation.

The SOPHiA DDM™ platform features intuitive variant filters and prioritization options to streamline the interpretation process and help you greatly reduce turnaround time.

2
  • GRCh38/hg38-based analytics for accurate variant annotation.
  • Dual Variant Pre-classification to improve assessment of variants pathogenicity based on both ACMG scores and our machine learning-based predictions
  • Virtual Panel to restrict the interpretation to sub-panels of genes using the HPO or OMIM browser
  • Cascading Filters to apply custom filtering options for quicker screening of relevant variants and save strategies for future analyses
  • Familial Variant Analysis (trio-analysis) to quickly identify causative variants by selecting different inheritance modes with a single mouse click to shorten the candidate variant list accordingly

Through SOPHiA DDM™, you can also have access to Alamut Visual Plus, a full-genome browser that integrates numerous curated genomic and literature databases, guidelines, missense and slicing predictors, thus enabling a deeper variant exploration.

In addition to the Clinical Exome kit, we have other more specific panels for clinical diagnosis in areas such as metabolism, oncology, genetics or cardiology.

Area:

Exomes, Molecular Genetics
Consult our experts

Google reCaptcha: Invalid site key.

Related products

Agilent SureSelect Human All Exon V8.

High-performance exome for the enrichment of human coding regions, with updated coverage of RefSeq, CCDS and GENCODE, including the TERT promoter and difficult-to-capture exons. 3.- Detailed Description Operating principle SureSelect Human All Exon V8 is based on NGS library preparation and capture enrichment of target regions of the human exome. The workflow is compatible with…
Agilent
Next Generation Sequencing (NGS)

Duplicα RealTime ApoE Genotyping Kit

In vitro diagnostic kit based on real-time PCR for the qualitative detection of the ApoE*E2, ApoE*E3 and ApoE*E4 alleles in human genomic DNA. Detailed Description Operating principle The kit is based on the specific amplification of target sequences by Real-Time PCR, using specific fluorescent probes. Allelic discrimination is performed using labelled probes: FAM (6-carboxyfluorescein) to…
Clonit
Real Time PCR (qPCR)

Twist Custom Panels for NGS Applications

Twist custom panels are highly customisable solutions, allowing the exact selection of regions, genes, pathways or variants of interest. They are designed to offer high performance, flexibility and precision in all types of applications and starting samples. Detailed Description Operating principle: In practice, the use of custom panels makes it possible to overcome the limitations…
SOPHIA Genetics
Next Generation Sequencing (NGS)

SOPHiA DDM™ Community Pharmacogenomics Solution

Pharmacogenomics solution for NGS analysis that combines a capture enrichment kit with the analytical capabilities of the SOPHiA DDM™ platform. It is designed to evaluate and report genomic variants associated with pharmacogenomics in an accelerated manner. Detailed description Operating principle The solution integrates a capture enrichment kit with the bioinformatics analysis of the SOPHiA DDM™…
SOPHIA Genetics
Next Generation Sequencing (NGS)